# A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

> **NCT07205198** · PHASE1 · RECRUITING · sponsor: **Shanghai Institute Of Biological Products** · enrollment: 160 (estimated)

## Conditions studied

- Advanced Tumors

## Interventions

- **DRUG:** SIBP-A10

## Key facts

- **NCT ID:** NCT07205198
- **Lead sponsor:** Shanghai Institute Of Biological Products
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-31
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07205198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07205198, "A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07205198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*